These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 8962299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral.
    Masri MA, Barbari A, Stephan A, Kamel G, Frem G, Younan F, Rizk S, Moubarak R, Karam A.
    Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M, Satta R, Branca GF, Pala PG, Serra G, Satta RP, Sorba G.
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
    Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA, Eisen HJ.
    Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
    [No Abstract] [Full Text] [Related]

  • 29. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR, Weiskittel P, Shah M, Peddi VR, Canafax D, Schroeder TJ.
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Experience with clinical use of Sandimmun Neoral in renal transplant patients.
    Min ZL, Zhao M, Zhu YH, Qi J, Wang LM, Wang YW.
    Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692
    [No Abstract] [Full Text] [Related]

  • 32. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A, Lee WT, Jacob E, Woo KT.
    Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
    Kelles A, Herman J, Tjandra-Maga TB, Van Damme-Lombaerts R.
    Transplant Proc; 1998 Aug; 30(5):1995-6. PubMed ID: 9723366
    [No Abstract] [Full Text] [Related]

  • 35. Cyclosporine pharmacology.
    Lee JI, Canafax DM.
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative pharmacokinetic study of Neoral vs Sandimmun in Japanese stable renal allograft recipients.
    Takahara S, Ohta K, Ohashi Y, Namii Y, Uchida K, Okuyama A, Kainuma H, Takagi H, Takahashi K, Morikawa H.
    Transplant Proc; 1999 Nov; 31(7):3089-92. PubMed ID: 10610595
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.